Uncontrolled Moderate-to-severe Asthma Study

Asthma Trials in Columbus

Aventiv Research is currently participating in an uncontrolled moderate-to-severe asthma Study at our Dublin, Ohio location. Asthma is a chronic lung disease that affects about 1 in 12 people, and that number continues to grow. The disease inflames and narrows airways, thus causing periods of chest tightness, coughing, shortness of breath, and wheezing on a recurring basis.

Enroll Now

Uncontrolled Moderate-to-severe Asthma Study

The primary objective of this clinical trial is to evaluate the efficacy of safety of an investigational drug in adults with moderate-to-severe uncontrolled asthma compared to a placebo.

You may qualify for this study if you:

• Are 18 to 65 years of age
• Have been diagnosed with moderate-to-severe asthma for at least 12 months
• Have a documented history of at least 1 asthma exacerbation in the past 12 months
• Are currently treated with a medium-to-high dose inhaled corticosteroid for at least 12 months and on a stable dose for at least 3 months
• Have a bodyweight of at least 40 kg and BMI less than 35 kg/m2